These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 25012200

  • 1. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J, Gompel A, Plu-Bureau G.
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [Abstract] [Full Text] [Related]

  • 2. Hormonal contraceptives and venous thromboembolism: an epidemiological update.
    Plu-Bureau G, Maitrot-Mantelet L, Hugon-Rodin J, Canonico M.
    Best Pract Res Clin Endocrinol Metab; 2013 Feb; 27(1):25-34. PubMed ID: 23384743
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Thrombotic risks of oral contraceptives.
    Rott H.
    Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
    [Abstract] [Full Text] [Related]

  • 5. [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
    Plu-Bureau G, Sabbagh E, Hugon-Rodin J.
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):823-833. PubMed ID: 30389542
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS, Kaye JA, Russmann S, Jick H.
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [Abstract] [Full Text] [Related]

  • 9. [Oral contraceptive pill and thrombotic risk: epidemiological studies].
    Fruzzetti F, Perini D, Spirito N, Manca R.
    Minerva Ginecol; 2012 Dec; 64(6):539-49. PubMed ID: 23232538
    [Abstract] [Full Text] [Related]

  • 10. Hormonal contraception and thrombosis.
    Sitruk-Ware R.
    Fertil Steril; 2016 Nov; 106(6):1289-1294. PubMed ID: 27678035
    [Abstract] [Full Text] [Related]

  • 11. Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.
    Hugon-Rodin J, Horellou MH, Conard J, Gompel A, Plu-Bureau G.
    Thromb Haemost; 2018 May; 118(5):922-928. PubMed ID: 29614525
    [Abstract] [Full Text] [Related]

  • 12. Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen.
    Rott H.
    Hamostaseologie; 2019 Feb; 39(1):42-48. PubMed ID: 30669160
    [Abstract] [Full Text] [Related]

  • 13. Systemic hormonal contraception and risk of venous thromboembolism.
    Heikinheimo O, Toffol E, Partonen T, But A, Latvala A, Haukka J.
    Acta Obstet Gynecol Scand; 2022 Aug; 101(8):846-855. PubMed ID: 35633036
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Contraception, venous thrombosis and biological plausability.
    Rott H.
    Minerva Med; 2013 Apr; 104(2):161-7. PubMed ID: 23514992
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N, Smith KP.
    Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
    [Abstract] [Full Text] [Related]

  • 18. Hormonal contraception, thrombosis and age.
    Lidegaard Ø.
    Expert Opin Drug Saf; 2014 Oct; 13(10):1353-60. PubMed ID: 25227335
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Toward a new concept of "natural balance" in oral estroprogestin contraception.
    Chabbert-Buffet N, Gerris J, Jamin C, Lello S, Lete I, Lobo P, Nappi RE, Pintiaux A.
    Gynecol Endocrinol; 2013 Oct; 29(10):891-6. PubMed ID: 23931030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.